Welcome to LookChem.com Sign In|Join Free
  • or
(S)-benzyl 2-(tert-butoxycarbonylamino)-4-hydroxy-3 ,3-dimethylbutanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

858034-62-5

Post Buying Request

858034-62-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

858034-62-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 858034-62-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,0,3 and 4 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 858034-62:
(8*8)+(7*5)+(6*8)+(5*0)+(4*3)+(3*4)+(2*6)+(1*2)=185
185 % 10 = 5
So 858034-62-5 is a valid CAS Registry Number.

858034-62-5Downstream Products

858034-62-5Relevant academic research and scientific papers

Structure-activity relationship of daptomycin analogues with substitution at (2S, 3R) 3-methyl glutamic acid position

Lin, Du'an,Lam, Hiu Yung,Han, Wenbo,Cotroneo, Nicole,Pandya, Bhaumik A.,Li, Xuechen

, p. 456 - 459 (2017)

Daptomycin is a highly effective lipopeptide antibiotic against Gram-positive pathogens. The presence of (2S, 3R) 3-methyl glutamic acid (mGlu) in daptomycin has been found to be important to the antibacterial activity. However the role of (2S, 3R) mGlu i

Hepatitis C Virus Inhibitors

-

, (2015/02/25)

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

-

, (2015/02/02)

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

Hepatitis C Virus Inhibitors

-

, (2013/07/25)

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 858034-62-5